Director, Biologics Development

Dyne TherapeuticsWaltham, MA
$190,000 - $230,000Onsite

About The Position

The Director, Biologics Development leads the strategy and execution of biologics development activities to advance Dyne’s therapeutic programs from early-stage development through clinical and commercial readiness. This role shapes development strategies, ensures alignment across cross-functional teams, and drives technical excellence in biologics development. The Director applies deep scientific and industry expertise to solve complex challenges, influence decision-making, and enable successful program delivery that supports Dyne’s mission of delivering meaningful outcomes for patients. The role will ensure the delivery of robust, scalable, and cost-effective second-generation manufacturing processes, serve as the primary technical lead for external CDMOs, driving aggressive timelines while delivering well-characterized products optimized for our proprietary bioconjugation platform. As a core CMC team member, the Director of Biologics Development will steer the development of preclinical assets and define CMC strategies within a matrixed environment. The role will play a critical role in global regulatory filings (IND, IMPD, etc.) by authoring and reviewing key Module 3 sections. This role is based in Waltham, MA and requires regular onsite presence, typically four to five days per week.

Requirements

  • Bachelor’s degree in Biology, Biochemistry, Pharmaceutical Sciences, or related discipline; advanced degree preferred
  • 10+ years of biopharmaceutical industry experience with demonstrated progression in biologics development
  • Experience leading teams or cross-functional initiatives in a matrixed environment
  • Proven track record advancing biologics programs from early development through clinical cGMP manufacturing
  • Deep expertise in protein expression, purification, and biologics process development
  • Experience defining and executing CMC strategies from pre-IND through clinical development
  • Strong track record managing CDMOs, including oversight and technology transfer
  • Working knowledge of FDA, EMA, and ICH guidelines, with experience contributing to Module 3 regulatory filings
  • Experience in analytical development, including impurity control, viral safety, and physicochemical characterization
  • Demonstrated ability to lead complex programs and influence cross-functional teams and external partners
  • Strong strategic thinking, problem-solving, and decision-making skills in a fast-paced environment
  • Excellent communication skills, with the ability to clearly convey complex technical concepts
  • Effective project management capabilities, balancing competing priorities and timelines

Responsibilities

  • Lead the design, optimization, and execution of process development for biologics, ensuring scalability for clinical and commercial supply.
  • Proactively identify and implement emerging technologies and continuous improvement initiatives to enhance product quality and manufacturing efficiency.
  • Define Dyne’s strategy for implementation of new technologies to lower cost-of-goods
  • Act as the primary CMC representative for Technical Development to internal teams, defining and defending compliant, phase-appropriate CMC strategies in a matrixed environment. Prepare technical source documents, publications, and oral presentations
  • Function as liaison with Research and Platform Innovation teams, to prepare new biologics assets for Candidate Nomination, steer Developability and Manufacturability Assessments, and ensure a seamless transition into Technical Development
  • Lead the selection, qualification, and strategic management of external CDMOs to ensure alignment with corporate goals and aggressive timelines.
  • Spearhead the seamless transfer of biologics processes to external partners, ensuring technical success and data integrity.
  • Serve as the technical lead for resolving complex manufacturing or analytical challenges, driving timely and data-driven solutions.
  • Lead the preparation and technical review of global regulatory filings (IND, IMPD, etc.), ensuring high-quality, submission-ready Module 3 content.
  • Review and approve critical development and cGMP documentation, including Tech Transfer protocols, Master Batch Records (MBRs), and Campaign Summary Reports.
  • Oversee the creation of technical source documents, publications, and high-level presentations for internal stakeholders and external forums.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service